References and Notes
<A NAME="RD08007ST-1A">1a</A>
Elderfield RC. In Heterocyclic Compounds
Vol. 4:
Elderfield RC.
John Wiley Inc.;
New York / London:
1960.
Chap. 1.
p.1
<A NAME="RD08007ST-1B">1b</A>
Wright CW.
Addac-Kyereme J.
Breen AG.
Brown JE.
Cox MF.
Croft SL.
Gokcek Y.
Kendrick H.
Phillips RM.
Pollet PL.
J. Med. Chem.
2001,
44:
3187
<A NAME="RD08007ST-1C">1c</A>
Sahu NS.
Pal C.
Mandal NB.
Banerjee S.
Raha M.
Kundu AP.
Basu A.
Ghosh M.
Roy K.
Bandyopadhyay S.
Bioorg. Med. Chem.
2002,
10:
1687
<A NAME="RD08007ST-1D">1d</A>
Bringmann G.
Reichert Y.
Kane V.
Tetrahedron
2004,
60:
3539
<A NAME="RD08007ST-1E">1e</A>
Kournetsov VV.
Mendez LYV.
Gomez CMM.
Curr. Org. Chem.
2005,
9:
141
<A NAME="RD08007ST-2">2</A>
Antimalarial Drug II
Peters W.
Richards WHG.
Springer Verlag;
Berlin / Heidelberg / New York / Tokyo:
1984.
<A NAME="RD08007ST-3A">3a</A>
Rigby JH.
Danca DM.
Tetrahedron Lett.
1997,
38:
4969
<A NAME="RD08007ST-3B">3b</A>
Leue S.
Miao W.
Kanazawa A.
Genisson Y.
Garcon S.
Greene AE.
J. Chem. Soc., Perkin Trans. 1
2001,
2903
<A NAME="RD08007ST-3C">3c</A>
Comin DL.
Nolan JM.
Org. Lett.
2001,
3:
1611
<A NAME="RD08007ST-4A">4a</A>
Toyata M.
Komori C.
Ihara M.
Heterocycles
2002,
56:
101
<A NAME="RD08007ST-4B">4b</A>
Chavan SP.
Sivappa R.
Tetrahedron Lett.
2004,
45:
3113
<A NAME="RD08007ST-4C">4c</A>
Chavan SP.
Sivappa R.
Tetrahedron
2004,
60:
9931
<A NAME="RD08007ST-4D">4d</A>
Harayama T.
Morikami Y.
Shigeta Y.
Abe H.
Takeuchi Y.
Synlett
2003,
847
<A NAME="RD08007ST-5">5</A>
Ma Z.
Lee DYZ.
Tetrahedron Lett.
2004,
45:
6721
<A NAME="RD08007ST-6">6</A>
Carles L.
Narkunan K.
Penlou S.
Rousset L.
Bouchu D.
Ciufolini MA.
J. Org. Chem.
2002,
67:
4304
<A NAME="RD08007ST-7A">7a</A>
Tennant G.
J. Chem. Soc. C
1966,
2290
<A NAME="RD08007ST-7B">7b</A>
Sutherland DR.
Tennant G.
J. Chem. Soc., Perkin Trans. 1
1974,
534
<A NAME="RD08007ST-7C">7c</A>
Westerlund C.
J. Heterocycl. Chem.
1980,
17:
1765
<A NAME="RD08007ST-7D">7d</A>
Lauria A.
Patella C.
Diana P.
Barraja P.
Montalbano A.
Cirrincione G.
Dattolo G.
Almerico AM.
Tetrahedron Lett.
2006,
47:
2187
<A NAME="RD08007ST-8">8</A>
Smalley RK.
Teguiche M.
Synthesis
1990,
654
<A NAME="RD08007ST-9A">9a</A>
Weber L.
Illegen K.
Almstetter M.
Synlett
1999,
366
<A NAME="RD08007ST-9B">9b</A>
Armstrong RW.
Combs AP.
Tempest PA.
Brown SD.
Keating TA.
Acc. Chem. Rev.
1996,
29:
123
<A NAME="RD08007ST-10A">10a</A>
Shestopalov AM.
Emeliyanova YM.
Shestiopolov AA.
Rodinovskaya IA.
Niazimbetova ZI.
Evans DH.
Org. Lett.
2002,
423
<A NAME="RD08007ST-10B">10b</A>
List B.
Castello C.
Synlett
2001,
1687
<A NAME="RD08007ST-10C">10c</A>
Nair V.
Vinod AU.
Rajesh C.
J. Org. Chem.
2001,
66:
4427
<A NAME="RD08007ST-10D">10d</A>
Bagley MC.
Cale JW.
Bower J.
Chem. Commun.
2002,
1682
<A NAME="RD08007ST-10E">10e</A>
Cheng JF.
Chen M.
Arthenius T.
Nadzen A.
Tetrahedron Lett.
2002,
43:
6293
<A NAME="RD08007ST-10F">10f</A>
Huma HZS.
Halder R.
Kalra SS.
Das J.
Iqbal J.
Tetrahedron Lett.
2002,
43:
6485
<A NAME="RD08007ST-10G">10g</A>
Bertozzi F.
Gustafsson M.
Olsson R.
Org. Lett.
2002,
4:
3309
<A NAME="RD08007ST-10H">10h</A>
Bora U.
Saikia A.
Boruah RC.
Org. Lett.
2003,
5:
435
<A NAME="RD08007ST-10I">10i</A>
Dallinger D.
Gorobets NY.
Kappe CO.
Org. Lett.
2003,
5:
1205
<A NAME="RD08007ST-11A">11a</A>
Kalita PK.
Baruah B.
Bhuyan PJ.
Tetrahedron Lett.
2006,
47:
7779
<A NAME="RD08007ST-11B">11b</A>
Devi I.
Baruah B.
Bhuyan PJ.
Synlett
2006,
2593
<A NAME="RD08007ST-11C">11c</A>
Deb ML.
Bhuyan PJ.
Tetrahedron Lett.
2007,
48:
2159
<A NAME="RD08007ST-11D">11d</A>
Deb ML.
Bhuyan PJ.
Tetrahedron Lett.
2005,
46:
6453
<A NAME="RD08007ST-11E">11e</A>
Devi I.
Bhuyan PJ.
Synlett
2004,
283
<A NAME="RD08007ST-11F">11f</A>
Devi I.
Bhuyan PJ.
Tetrahedron Lett.
2004,
45:
8625
<A NAME="RD08007ST-11G">11g</A>
Devi I.
Bhuyan PJ.
Tetrahedron Lett.
2004,
45:
7727
<A NAME="RD08007ST-12">12</A>
Three-Component Reaction
To a mixture of 2-chloro-3-formylquinoline (2a, 192 mg, 1 mmol), ethyl cyanoacetate (3a, 140 mg, 1.24 mmol) and NaN3 (4, 80 mg, 1.24 mmol) in DMF (10 mL) were added two drops of water. A catalytic amount
(1-2 drops) of Et3N was then added to the reaction mixture and it was allowed to stir for 4 h at 50-60
°C. After completion of the reaction, the mixture was cooled to r.t. and poured into
H2O under continuous stirring. A brown solid precipitated that was shown to be almost
totally pure 5a. However, it was further purified by preparative TLC using EtOAc-hexane (3:7); mp
205 °C, yield 234 mg (80%). 1H NMR (CDCl3): δ = 1.43 (t, 3 H), 4.32 (q, 2 H), 7.26 (s, 1 H), 7.60-8.05 (m, 4 H), 8.63 (s, 1
H). 13C NMR (CDCl3): δ = 14.50 (CH3), 61.20 (CH2C=O), 112.55 (C-5), 123.75 (C-4), 124.00 (C-2), 126.20 (C-7), 127.45 (C-3), 127.70
(C-6), 131.00 (C-6a), 136.20 (C-11b), 138.36 (C-8), 145.12 (C-8a), 146.67 (C-5a),
151.25 (C-1a), 171.75 (C=O). MS: m/z = 316 [M + Na]+. IR (CHCl3): 2923.70, 2852.60, 1742.80 cm-1. Anal. Calcd for C15N5O2H11: C, 61.43; H, 3.75; N, 23.89. Found: C, 61.43; H, 3.82; N, 23.95.
<A NAME="RD08007ST-13">13</A>
2-Chloro-3-formyl quinoline (2a, 384 mg, 2 mmol) was mixed with ethyl cyanoacetate (3a, 260 mg, 2.17 mml) in toluene (10 mL). One drop of piperidine was added and the reaction
mixture was allowed to stir at r.t. for 1 h. The solvent was evaporated and the yellow
solid obtained was purified by recrystallisation from EtOH.
Compound [Aa] (R1 = H, R2 = CO2Et): mp 110 °C, yield 516 mg (98%). 1H NMR (CDCl3): δ = 1.43 (t, 3 H), 4.43 (q, 2 H), 7.46-815 (m, 4 H), 8.74 (s, 1 H), 9.05 (s, 1
H). IR (CHCl3): 2226.70, 1730.90 cm-1.
<A NAME="RD08007ST-14">14</A>
The condensed product [Aa] (286 mg, 1 mmol) was mixed with NaN3 (4, 80 mg, 1.24 mmol) in DMF (10 mL) and 2 drops of H2O were added. The reaction mixture was allowed to stir for 4 h at 50-60 °C. After
completion of the reaction the mixture was cooled to r.t. and poured into H2O under continuous stirring. A brown coloured solid which appeared was filtered and
purified by preparative TLC using EtOAc-hexane (3:7) to furnish 5a (176 mg, 60%).